Catalyst Pharmaceuticals Inc (CPRX)

Payables turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cost of revenue	US$ in thousands	218,242	93,674	71,512	61,273	51,640
Payables	US$ in thousands	14,795	3,975	2,768	4,256	4,117
Payables turnover		14.75	23.57	25.84	14.40	12.54

December 31, 2023 calculation

Payables turnover = Cost of revenue ÷ Payables
= $218,242K ÷ $14,795K
= 14.75

The payables turnover ratio for Catalyst Pharmaceuticals Inc has fluctuated over the past five years, indicating varying efficiency in managing its accounts payable. The ratio decreased from 12.54 in 2019 to 14.40 in 2020 before experiencing a substantial increase to 25.84 in 2021, reflecting a significant improvement in the company's ability to pay off its suppliers. This positive trend continued in 2022 with a further increase to 23.57. However, there was a slight decrease in payables turnover to 14.75 in 2023, suggesting a potential elongation in the company's payment cycle or changes in its relationship with suppliers. Overall, Catalyst Pharmaceuticals Inc's payables turnover ratios demonstrate a mix of efficiency levels in managing its accounts payable over the five-year period.